These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15117097)

  • 1. Bupropion as an aid to smoking cessation: a review of real-life effectiveness.
    Holmes S; Zwar N; Jiménez-Ruiz CA; Ryan PJ; Browning D; Bergmann L; Johnston JA
    Int J Clin Pract; 2004 Mar; 58(3):285-91. PubMed ID: 15117097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of bupropion in the management of smoking cessation.
    Jorenby D
    Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience.
    Ferry L; Johnston JA
    Int J Clin Pract; 2003 Apr; 57(3):224-30. PubMed ID: 12723728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of sustained-release bupropion in specific patient populations for smoking cessation.
    Tonstad S
    Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of bupropion for smoking cessation during pregnancy.
    Chan B; Einarson A; Koren G
    J Addict Dis; 2005; 24(2):19-23. PubMed ID: 15784520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of bupropion SR for nicotine-dependent smokers: problems in a practice setting.
    Kohlenberg BS; Antonuccio DO; Hayes SC; Gifford EV; Piasecki MP
    Psychother Psychosom; 2004; 73(4):252-4. PubMed ID: 15184720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.
    Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS
    JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does bupropion have advantages over other medical therapies in the cessation of smoking?
    Tonstad S; Johnston JA
    Expert Opin Pharmacother; 2004 Apr; 5(4):727-34. PubMed ID: 15102559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation.
    White WD; Crockford D; Patten S; El-Guebaly N
    Nicotine Tob Res; 2005 Oct; 7(5):809-13. PubMed ID: 16191752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N; Nikoloutsou I; Katsani G; Dima E; Fransis K; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.
    Balfour DJ
    Int J Clin Pract; 2001; 55(1):53-7. PubMed ID: 11219320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bupropion. An antidepressant used to help smoking cessation].
    Taeron C
    Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation.
    Johnston AJ; Ascher J; Leadbetter R; Schmith VD; Patel DK; Durcan M; Bentley B
    Drugs; 2002; 62 Suppl 2():11-24. PubMed ID: 12109932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent Smoking Cessation With Bupropion: The Role of Adherence.
    Leischow SJ; Muramoto ML; Matthews E; Floden LL; Grana RA
    Nicotine Tob Res; 2016 May; 18(5):1202-5. PubMed ID: 26567274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and safety of sustained-release bupropion in the management of smoking cessation.
    Aubin HJ
    Drugs; 2002; 62 Suppl 2():45-52. PubMed ID: 12109935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of bupropion SR in cigarette smoking cessation.
    Wilkes S
    Int J Chron Obstruct Pulmon Dis; 2008; 3(1):45-53. PubMed ID: 18488428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion SR and contingency management for adolescent smoking cessation.
    Gray KM; Carpenter MJ; Baker NL; Hartwell KJ; Lewis AL; Hiott DW; Deas D; Upadhyaya HP
    J Subst Abuse Treat; 2011 Jan; 40(1):77-86. PubMed ID: 20934835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.